Pharma

Your Article Summary

See Latest Articles

New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09

Chugai Pharmaceutical Co., Ltd. ("Chugai")and Taisho Pharmaceutical Co., Ltd. ("Taisho"), announced that a New Drug Application was filed to the Ministry of Health, Labour and Welfare for the active vitamin D3 derivative which was discovered by Chugai and co–developed by the two companies for the indication of osteoporosis.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Harris Corp. Buys VA Contractor
HealthDataManagement, 11/23/09

Wearable Sensors to Detect Agents, Disease
HealthDataManagement, 11/23/09

Carillion to install bedside terminals at LHSC
Canadian Healthcare Technology, 11/20/09

 See all of M&A/Partnerships

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

GSK Regulatory Update: Avodart
GlaxoSmithKline, 11/24/09

Baytubes carbon nanotubes in marine coatings help reduce frictional resistance
BayNews International, 11/24/09

Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09

 See all of Regulatory Issues